
Opinion|Videos|April 23, 2025
Off Fluctuations in Parkinson Disease
Panelists discuss how off fluctuations in Parkinson disease become increasingly prevalent as the disease progresses, significantly impacting patient quality of life through reduced mobility, independence, and overall well-being.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
Prevalence of Off Fluctuations and Quality-of-Life Impact
Off Fluctuations Prevalence:
- Approximately 40% of patients experience motor fluctuations after 4 to 6 years of levodopa therapy
- By 10 years of treatment, up to 90% of patients develop off episodes (Aradi 2020)
- Off periods increase in frequency and duration as disease progresses
- Early fluctuations may be end-of-dose wearing off, progressing to unpredictable on-off phenomena
Quality-of-Life Impact:
- Progressive deterioration in activities of daily living and independence
- Increased caregiver burden and health care utilization
- Significant psychological impact: anxiety, depression, social isolation
- Mobility limitations affecting employment, social interactions, and self-care
- Sleep disturbances and fatigue compound functional limitations
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
3
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
4
CD40L Inhibitor Frexalimab Enters Phase 3 FREXITE Trial of Non-Relapsing Secondary Progressive Multiple Sclerosis
5











